BELBUCA: payments to doctors
Payments that named BELBUCA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.4M
- Providers
- 12,409
- Transactions
- 81,916
- Average per transaction
- $53
The per-transaction average — $53 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,409 providers the average total is $352, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Collegium Pharmaceutical, Inc. | $3,350,195 | 76.8% |
| Biodelivery Sciences International, Inc. | $1,012,174 | 23.2% |